StockData
GT Biopharma, Inc. logo

GT Biopharma, Inc. (GTBP) stock

GTBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$3.18−0.35 (-10.04%)

Close on Nov 17, 2026Market cap $143.45MP/E –Yield –

GT Biopharma EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

GT Biopharma's EV/EBITDA was 537.5× on Jan 29, 2021.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2021Jan 29, 2021537.5×+52.6
2020Dec 31, 2020484.9×–

More GT Biopharma figures

See a number that looks wrong?